GEORGE COUSIN: Open Payments
NPI 1275532186 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 105 payments from 23 companies in 2025. Trend: 2023 $1,745 · 2024 $1,611 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $255 |
| PFIZER INC. | 12 | $221 |
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| ABBVIE INC. | 12 | $161 |
| Corium, LLC | 10 | $122 |
| Verona Pharma, Inc. | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
Products named: Azstarys, PREVNAR 20, FARXIGA, Ozempic, Rybelsus, Ohtuvayre, VRAYLAR, LEQVIO.
Industry payments across LA — which companies pay providers there.
